Results 11 to 20 of about 10,512 (252)

Cabergoline Use and Pregnancy Outcomes: A Systematic Review. [PDF]

Birth Defects Res
ABSTRACT Introduction Lack of available expert guidelines leads clinicians to interrupt cabergoline treatment upon confirmation of pregnancy and consider switching to bromocriptine, which is more commonly used during pregnancy but is poorly tolerated.
Otis AS, Brochet MS, Tremblay Z, Balayla J, Dahdouh EM.   +4 more
europepmc   +2 more sources

Exploring retinal vessel density alterations in prolactinoma patients: Insights from OCTA imaging [PDF]

Indian Journal of Ophthalmology
Purpose: To investigate microvascular changes in the macular and peripapillary area in prolactinoma patients by using optical coherence tomography angiography (OCTA). Design: A retrospective study.
Serife Ciloglu Hayat, Yusuf Cem Yilmaz, Merve Kelebek, Esra Hatipoglu   +3 more
doaj   +2 more sources

MicroRNA networks in prolactinoma tumorigenesis: a scoping review [PDF]

Cancer Cell International
Background Prolactinoma is the leading type of pituitary adenoma. Aside from the mass-like effect of prolactinoma, its hormonal effect is the main pathological cause of endocrine dysregulation and infertility.
Sevil Ghaffarzadeh Rad, Fatemeh Nejadi Orang, Mahdi Abdoli Shadbad   +2 more
doaj   +2 more sources

A Comprehensive Neurological Study on the Relationship Between Prolactinoma and Alzheimer’s Disease [PDF]

Alzheimers Dement
Abstract Background Although most pituitary tumors are benign, functioning pituitary tumors are dangerous as they produce and deteriorate the endocrine hormones. Prolactinomas are one of these tumors that arise from lactotroph cells of the anterior pituitary, and they're about 40% of all pituitary adenomas.
Zid M, El‐Satar Y, Shahin A.
europepmc   +2 more sources

Giant prolactinoma with progressive cranial settling and central herniation: a case report [PDF]

Journal of Medical Case Reports
Background Giant prolactinoma (size > 4 cm) is a rare condition and accounts for less than 1% of pituitary adenomas. In even rarer cases, these lesions may involve craniocervical structures requiring surgical intervention. The present case is the largest
Taha Shahbazi, Soheil Abdollahi Yeganeh, Shiva Borzouei, Mahdi Arjipour   +3 more
doaj   +2 more sources

Transcriptomic analysis of the anti-tumor effects of leflunomide in prolactinoma [PDF]

Scientific Reports
Leflunomide’s anti-tumor effects have been investigated in various types of tumors; however, its impact on pituitary adenoma, particularly prolactinoma, is unclear.
Xiangdong Pei, Yuyang Peng, Huachun Yin, Zhenle Zang, Kaifeng Shen, Song Li, Chunqing Zhang   +6 more
doaj   +2 more sources

miR-21-5p Targets PIK3R1 to Regulate the NF-κB Signaling Pathway, Inhibiting the Invasion and Progression of Prolactinoma. [PDF]

Int J Endocrinol
Prolactinomas (PRLs) are benign tumors with malignant characteristics that can invade the surrounding tissue structures and are challenging to treat. It has been reported that miR‐21‐5p expression in pituitary adenomas is correlated with tumor invasion and size. However, the mechanism of action of miR‐21‐5p in PRL remains unclear.
de Li M, Yang J, Wu X, Chen SS.
europepmc   +2 more sources

Inhibiting MAPK14 showed anti-prolactinoma effect

BMC Endocrine Disorders, 2020
Background The specific underlying pathogenesis of prolactinoma has not been clarified yet, to the best of our knowledge. p38 mitogen-activated protein kinase (MAPK) signaling including p38α MAPK (MAPK14), p38β (MAPK11), p38γ (MAPK12) and p38δ (MAPK13 ...
Qiao-yan Ding, Yu Zhang, Li Ma, Yong-gang Chen, Jin-hu Wu, Hong-feng Zhang, Xiong Wang   +6 more
doaj   +1 more source

Adverse body composition and lipid parameters in patients with prolactinoma: a case-control study

BMC Endocrine Disorders, 2021
Background Hyperprolactinaemia might cause adverse metabolic effects. The aim of our study was to compare parameters of body composition, glucose and lipid metabolism between untreated patients with prolactinoma and controls and to assess changes after ...
Anna Sophia Posawetz, Christian Trummer, Marlene Pandis, Felix Aberer, Thomas R. Pieber, Barbara Obermayer-Pietsch, Stefan Pilz, Verena Theiler-Schwetz   +7 more
doaj   +1 more source

Prolactinoma in a Dog [PDF]

Veterinary Pathology, 2017
A 12-year-old male Yorkshire Terrier was presented because of decreased appetite. Physical examination revealed mammary gland swelling and galactorrhea. Contrast-enhanced computed tomographic scanning of the skull indicated an enlarged pituitary gland, compatible with a pituitary tumor. The serum prolactin concentration was markedly elevated. One week
Cosio, Cristina, Sartori, Elena, Garatti, Marcello, Luccardini, Lorenzo, Grinwis, G. C. M., Kooistra, Hans S., Fracassi, Federico   +6 more
openaire   +5 more sources